SC insulin delivery creates a paradoxical peripheral hyperinsulinemia necessary to achieve minimal insulin concentration in the portal system able to inhibit hepatic glucose production, thus, preventing fasting hyperglycemia. This evidence concerns the gene INS and Hyperinsulinemia.